Present and future treatment of advanced non–small cell lung cancer

This publication has 29 references indexed in Scilit:

• Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1998
• Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
  European Journal Of Cancer, 1998
• 39 Six year follow up of the European Multicentre Randomised Study comparing Navelbine (NVB) alone vs NVB + Cisplatin (CDDP) vs Vindesine (VDS) + CDDP in 612 patients (pts) with advanced non-small cell lung cancer (NSCLC)
  Lung Cancer, 1997
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
  Journal of Clinical Oncology, 1994
• Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
  Annals of Oncology, 1994
• The Case for Mitomycin in Non-Small Cell Lung Cancer
  Oncology, 1993
• A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
  Cancer, 1992
• A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
  Journal of Clinical Oncology, 1992
• Vinca alkaloids in the treatment of non-small cell lung cancer
  Cancer Treatment Reviews, 1987